Patients with gynecologic cancer have new hope in a novel technology now offered at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center. A team of cancer specialists, led by Robert DeBernardo, MD, is ...
Jan 20, 2012
0
0
Emma Rossi, MD, in the UNC Department of Obstetric and Gynecology's Division of Gynecologic Oncology, has published a study in Lancet Oncology online that identifies sentinel-lymph-node mapping as a safer and less-invasive ...
Feb 24, 2017
0
29
A new study by researchers at the UCLA Jonsson Comprehensive Cancer Center found using percutaneous image guided needle based thermal ablation—the precise application of extreme heat or cold to a tumor using sophisticated ...
Mar 29, 2021
0
3
Personalized medicine is getting closer to reality for women with late-stage ovarian cancer. An experimental immunotherapy is in the works that can target an individual woman's tumor and extend the time period between initial ...
Mar 30, 2015
0
52
A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine® scientists to be less toxic to a young woman's fertility but extra tough on cancer. This is the first cancer drug tested ...
Mar 22, 2013
0
0
A study evaluating the effects of bariatric surgery on obese women most at risk for cancer has found that the weight-loss surgery slashed participants' weight by a third and eliminated precancerous uterine growths in those ...
Oct 1, 2015
0
46
Gynecologic cancers start in a woman's reproductive organs. The five main types are cervical, endometrial, ovarian, vaginal and vulvar cancer.
Sep 4, 2020
0
2
Two Johns Hopkins gynecologic surgeons are among the first in the nation to perform a robotic hysterectomy using a single, small incision.
May 30, 2013
1
0
(Medical Xpress) -- Older female cancer survivors are significantly more likely to suffer from long-term cognitive impairment after diagnosis and treatment compared to their twin sibling with no history of cancer, a USC study ...
Dec 20, 2011
0
0
By loading fragile RNA into silicon nanoparticles, researchers from The Methodist Hospital and two other institutions found a new drug delivery system can reduce the size of ovarian tumors by as much as 83 percent—and stop ...
Feb 14, 2013
0
0
